Replies to post #437 on Omeros Corporation (OMER)

[umiak]

Today— CMS has now approved Omidria as a non opiod pain management.
This will insure not having to do another raise while they wait for Narsoplimab’s approval and income flow.

Also, Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA
11/18/20